Effects of Physical Therapy on Improving Disc Height, Postural Stability, Pain and Function in Persons With Discogenic Low Back Pain

February 26, 2024 updated by: Foundation University Islamabad

Effects of Physical Therapy on Improving Disc Height Index, Postural Stability, Pain and Function in Persons With Discogenic Low Back Pain

Lumbar degenerative disc disease and discogenic low back pain is comparatively common and disabling musculoskeletal condition, however there is no conclusive evidence regarding the positive effects of conservative physical therapy management in terms of radiological changes and improvement in disc height. For this reason, the current study will not only look into the positive effects of conservative physical therapy on postural stability, pain and function, but also in terms of disc height in persons with discogenic low back pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
      • Islamabad, Pakistan, 66000
        • Foundation University Islamabad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 50 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Both male and female participants
  • Aged 18-50 years old
  • low back pain intensity less than 80/100mm on visual analogue scale
  • positive centralization phenomenon
  • low signal intensity of IV disc on T2 - weighted MRI
  • high intensity zone towards the posterior aspect of the disc on MRI

Exclusion Criteria:

  • Individuals with and any musculoskeletal, metabolic, or neurological disorders that may impair gait, postural stability or sensory integrity will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physical Therapy
Procedure: Mckenzie Extension Protocol
Mckenzie Extension Exercise Protocol will be performed by participants in prone position
Procedure: Lumbar SNAGs
Lumbar SNAGs will be performed in lumbar flexion and extension in standing Position
Device: Inferential therapy
4 pole inferential therapy in combination with superficial heating for 20 minutes
Procedure: Heat Therapy
superficial heating for 20 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Back Pain
Time Frame: 2 weeks
Pain will be measured via Visual Analogue Scale. A higher score signifies poor outcome.
2 weeks
Postural Stability
Time Frame: 2 weeks
Postural Stability will be measured via Biodex Balance System. A higher score signifies poor outcome.
2 weeks
Lumbar Disability
Time Frame: 2 weeks
Disability will be measured via Oswestry Disability Index.
2 weeks
Lumbar Range of Motion
Time Frame: 2 weeks
Lumbar Range of Motion will be measured via inclinometer. A higher score signifies good outcome.
2 weeks
Step length
Time Frame: 2 weeks
Step length during gait will be analyzed using observational gait analysis. A greater step length signifies better outcome
2 weeks
Stride length
Time Frame: 2 weeks
Stride length during gait will be analyzed using observational gait analysis. A greater stride length signifies better outcome
2 weeks
Gait velocity
Time Frame: 2 weeks
Velocity during gait will be analyzed using observational gait analysis. A greater gait velocity signifies better outcome
2 weeks
Disc Height
Time Frame: 2 weeks
Disc will be analyzed using Magnetic Resonance Imaging
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Foundation University Islamabad

Investigators

  • Principal Investigator: Muhammad Osama, PhD*, FUI
  • Principal Investigator: Aamer Naeem, PhD*, FUI

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2022

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

March 29, 2022

First Submitted That Met QC Criteria

April 6, 2022

First Posted (Actual)

April 13, 2022

Study Record Updates

Last Update Posted (Estimated)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 26, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FUI/CTR/2022/5

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe